Chemoinformaics analysis of Bergenin/cuscutin
| Molecular Weight | 328.273 | nRot | 2 |
| Heavy Atom Molecular Weight | 312.145 | nRig | 17 |
| Exact Molecular Weight | 328.079 | nRing | 3 |
| Solubility: LogS | -1.782 | nHRing | 2 |
| Solubility: LogP | -0.66 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 9 | APOL | 41.2667 |
| nHD | 5 | BPOL | 22.1273 |
| QED | 0.422 |
| Synth | 4.089 |
| Natural Product Likeliness | 2.626 |
| NR-PPAR-gamma | 0.644 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.26 |
| HIA | 0.837 |
| CACO-2 | -6.159 |
| MDCK | 0.0000856 |
| BBB | 0.662 |
| PPB | 0.323749 |
| VDSS | 0.684 |
| FU | 0.541584 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.087 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.271 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.343 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.165 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.048 |
| CL | 4.946 |
| T12 | 0.761 |
| hERG | 0.021 |
| Ames | 0.231 |
| ROA | 0.078 |
| SkinSen | 0.107 |
| Carcinogencity | 0.03 |
| EI | 0.013 |
| Respiratory | 0.049 |
| NR-Aromatase | 0.205 |
| Antiviral | Yes |
| Prediction | 0.616692 |